{"title":"更正“艾塞那肽用于严重肥胖青少年的减肥维持:一项随机、安慰剂对照试验”","authors":"","doi":"10.1002/oby.23843","DOIUrl":null,"url":null,"abstract":"<p>Fox CK, Clark JM, Rudser KD, et al. Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial. <i>Obesity (Silver Spring)</i>. 2022;30:1105-1115.</p><p>On page 1112, Table 2 was incorrect because of interchanged data from “BMI (kg/m<sup>2</sup>)” and “Percent of 95th BMI percentile.”</p><p>Below is the correct Table 2:</p><p>We apologize for this error.</p>","PeriodicalId":215,"journal":{"name":"Obesity","volume":"31 9","pages":"2440"},"PeriodicalIF":4.2000,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.23843","citationCount":"0","resultStr":"{\"title\":\"Correction to “Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial”\",\"authors\":\"\",\"doi\":\"10.1002/oby.23843\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Fox CK, Clark JM, Rudser KD, et al. Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial. <i>Obesity (Silver Spring)</i>. 2022;30:1105-1115.</p><p>On page 1112, Table 2 was incorrect because of interchanged data from “BMI (kg/m<sup>2</sup>)” and “Percent of 95th BMI percentile.”</p><p>Below is the correct Table 2:</p><p>We apologize for this error.</p>\",\"PeriodicalId\":215,\"journal\":{\"name\":\"Obesity\",\"volume\":\"31 9\",\"pages\":\"2440\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2023-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.23843\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/oby.23843\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/oby.23843","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
Fox CK, Clark JM, Rudser KD，等。艾塞那肽用于严重肥胖青少年的减肥维持:一项随机、安慰剂对照试验。肥胖(银泉)。2022; 30:1105 - 1115。在第1112页，由于“BMI (kg/m2)”和“第95个BMI百分位数的百分比”的数据互换，表2是不正确的。下面是正确的表2:我们为这个错误道歉。
Correction to “Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial”
Fox CK, Clark JM, Rudser KD, et al. Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial. Obesity (Silver Spring). 2022;30:1105-1115.
On page 1112, Table 2 was incorrect because of interchanged data from “BMI (kg/m2)” and “Percent of 95th BMI percentile.”
期刊介绍：
Obesity is the official journal of The Obesity Society and is the premier source of information for increasing knowledge, fostering translational research from basic to population science, and promoting better treatment for people with obesity. Obesity publishes important peer-reviewed research and cutting-edge reviews, commentaries, and public health and medical developments.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
